Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04730765Unknown

Quality of Life (QOL) After Elective Sigmoidectomy for Diverticular Diseases (DIVERTI)

Role: collaborator

NCT04879953Completed

Effect of the PIPAC on the Survival Rate of Patients With Peritoneal Carcinomatosis of Gastric Origin

Role: lead

NCT04327895Completed

Surgery in Context of Terrorist Attack : a Survey of French Surgeons

Role: collaborator

NCT04214340Completed

Appendicitis in Adults and Children in France-A Prospective Study by the French Surgical Association Multicenter Cohort

Role: lead

All 4 trials loaded